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ADC predicted poor histologic tumor response (TRG3–5 versus 
TRG1–2) with 91% sensitivity and 83% specificity (area under 
curve (AUC)=0.89, 95% confidence interval (CI)=0.74–1.0, 
p=0.001). Using the 30th percentile, an increase in ADC 
predicted poor PFS with 89% sensitivity and 71% specificity 
(AUC=0.75, 95% CI=0.54–0.95, p=0.051). Univariate regression 
analysis also revealed that the ADC increase was significantly 
associated to poor PFS (hazard ratio=9.7, 95% CI=1.21-78.30, 
p=0.033). 
 
Conclusion: By ADC histogram analysis of DWMRI acquired 
during NACT of LARC we identified low histogram percentiles 
as predictive of histologic tumor response in particular, but 
also long-term survival. The results require validation in 
larger, independent cohorts, but are promising for 
identification of patients that may benefit from 
individualized treatment approaches for improved disease 
outcome. 
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Purpose or Objective: Tumor hypoxia is prognostic for poor 
outcome after radiotherapy (RT). A method for non-invasive 
assessment of hypoxia is PET using hypoxia radiotracers such 
as FMISO. The goal of this study was to develop and evaluate 
a tool to simulate 3D oxygen distribution and the resulting 
FMISO accumulation on realistic vessel architectures, which 
can be compared to measured PET activities in small animal 
experiments. 
 
Material and Methods: Two FaDu tumors (human HNSCC) 
were grown on the right hind leg of nude mice. Imaging was 
performed after a growth phase of about 5 weeks. FMISO was 
injected into the tail vein of the anesthetized mice with an 
activity of ~12MBq for dynamic PET/MRI. ROIs inside the left 
ventricle and in the tumor were chosen to determine blood 
and tumor time activity curves (TACs). After image 
acquisition tumors were excised, snap frozen and cut into 
consecutive sections (20µm). Sections were stained with 
immunoflourescence-labeled antibodies for endothelial 
marker CD31 and scanned with a Zeiss Axioplan 2 
fluorescence microscope. Obtained immunofluorescence 
images were rigidly registered, manually adjusted and 
thresholded to create a binary 3D vessel map. These maps 
were used to simulate 3D oxygen distributions based on a 
Michaelis-Menten relation. Using the oxygen distribution and 
the dynamic activity in the left ventricle as input, FMISO 
retention was simulated on the same vessel maps. A tumor 
ROI was selected and its average activity at different time 
points post-injection (p.i.) compared against the measured 
activity in the same region on the PET scan (tumor TAC). To 
compare 3D and 2D simulations, the simulation were 
repeated in 2D on the individual sections, and 2D-based 
oxygen histograms and TACs were determined. 
 
Results: O2 histograms showed a large difference between 
2D and 3D simulations, with much lower values for 2D 
simulations than for 3D (5.94 mmHg vs 26.57 mmHg). Mean 
values were closer together (8.9 mmHg vs 13.2 mmHg). This 
is due to the large amount of anoxic voxels (pO2 < 1 mmHg) 
in the 2D simulation, which made up 17.5% of all simulated 
voxels in 2d, but less than 1% in the 3D simulations (see Table 
1). Visually, the 3D simulations result in a TAC with a similar 
overall shape compared to the TAC measured with small 
animal PET, but with a 20.7% overestimation of activity. 
However, the 2D simulations severely overestimated the total 
activity by 99.2% (2D) when compared against measured 
activity in the tumor after 90min as determined by PET. 
 
 
Conclusion: 3D simulations based on real 3D vessel 
architecture is feasible. Our FMISO simulations showed large 
discrepancies between 2D and 3D simulation approaches, 
with the 3D values being closer to the PET measurements. 
Verification of 3D tracer accumulation patterns in additional 
tumors against pimonidazole stainings is still necessary to 
validate and calibrate the method, with PET scans in the 
same test subject to confirm observed activity. 
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Purpose or Objective: Tumorcontrol of primary prostate 
cancer (PC) is dose dependent. Dominant index lesions (DIL) 
within the prostatic gland are responsible for local and 
distant failure. Radionuclide-labelled inhibitors of prostate-
specific membrane antigen (PSMA-PET) showed promising 
preclinical and clinical results in detection of primary 
prostate cancer. We correlated PET/histopathology using a 
new coregistration approach, which allows pixel-wise 
evaluation of the tracers performance in prostatic tissue. Aim 
of this work is to evaluate the diagnostic accuracy of 68Ga-
PSMA-PET/CT and to determine potential SUV-thresholds 
enabling a focal dose escalation on DIL delineated by PET. 
 
Material and Methods: 10 patients with primary PC and 
68Ga-PSMA-PET/CT were enrolled. After prostatectomy, 
thorough histopathological preparation and anatomical-based 
coregistration between in-vivo and ex-vivo material was 
performed. Simulated PET-images were generated out of 
blurred 3D histopathological tumor distribution (histoPET). 
The coregistration was further optimized by matching 
histoPET information with the in-vivo PET signal. The tracer 
performance was evaluated by coefficient of determination 
(R²) between histoPET/PSMA-PET patterns and SUV-values 
within different tissue types. 
 
Results: 1 patient was excluded due to imprecise 
pathological preparation. Mean R² value was 60 % (± SD 15.2, 
range: 42.5-81.6). SUVmax of PSMA-PET was located in non 
resolution adapated / resolution adapted PC-tissue in 
80%/90% of patients. Mean SUVmean in non resolution 
adapted PC and non-PC tissue was 6.1 (range: 2 – 21) and 2.7 
(range: 1.3 – 8.2), respectively. The ratio between SUVmean 
in PC / non-PC was 2.2 (SD ± 0.6). 
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Conclusion: Using a sophisticated approach for 
PET/histopathology coregistration PSMA-PET/CT yielded high 
R²-values which can be translated in excellent overlap with 
PCa. Furthermore, we were able to provide SUV-guidance 
values for PSMA-PET/CT which opens the opportunity for 
SUV-based GTV-delineation techniques using PSMA-PET as a 
base for focal dose escalation on DIL. 
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Purpose or Objective: To assess the potential role for a CT-
based, bone texture analysis as a predictive factor of bone 
radiation damage in patients undergoing radiotherapy (RT) 
for pelvic malignancies. 
 
Material and Methods: We performed a retrospective 
analysis of suitable patients treated with RT for pelvic 
malignancies from January 2010 to December 2014. The 
DICOM CT data acquired for RT planning were collected, and 
used for a homemade ImageJ macro analysis. Two region of 
interest (ROI) were selected: the L5 vertebral body and the 
femoral heads. Typical texture analysis (TA) parameters were 
retrospectively evaluated: mean (M), standard deviation (SD), 
skewness (SK), kurtisis (K), entropy (E) and uniformity (U). 
The patients who developed bone RT-related damages (i.e.: 
pelvic bone stress fracture, radiation osteitis, insufficiency 
fractures) during the follow-up constitute the study patients 
(SP) group. The TA data were collected for a comparative 
analysis also in a control group of patients (CP: 2:1 ratio, 
with respect to SP) not developing bone damages. The CPs 
were matched taking into account: age, sex, type of tumor, 
intent of postoperative treatment, comparable doses to the 
considered organs-at-risk. As for the statistical comparisons, 
we performed a univariate analysis (Pearson correlation) and 
a multivariate analysis (logistic regression) using the SPSS 
software 17.0. 
 
Results: Twenty-four SPs and 48 CPs are the subject of this 
report. Out of SPs, postoperative RT was delivered for 
cancer: of the digestive tract (anal or rectal) in thirteen 
patients (54%); of the female reproductive organs 
(endometrial or cervical) in 9 (37%); and of the excretory 
apparatus (prostate or bladder) in 3 patients (9%). In the 
comparison between SP and CP groups, the univariate 
analysis showed a significant correlation of the ROI 
parameters of L5: SD (p: 0,012); K (p<0,001), E (p: 0.001); U 
(p: 0,008), and of the femoral head: M (p<0,001); SD 
(p<0,001), with the development of bone damage. The 
logistic regression highlighted a significant correlation with 
the ROI parameters of L5: E (p:0.004); U (p:0,014), and 
femoral head M (p:0,022); and -SD (p:0,042), with an Overall 
Model Nagelkerke R Square of 0,590. 
 
Conclusion: These results (with the limit of a small series) 
and those reported in previous related studies deserve some 
interest, since the knowledge of predictive factors of bone 
radiation damage might help in patients’ selection for pelvic 
RT, and in identifying suitable dose constraints for the bony 
pelvis in RT planning for patients at risk. 
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Purpose or Objective: In case of cervix cancer irradiation, 
parameters extracted from initial 18F-FDG-PET images can be 
used to predict recurrence. FDG PET parameters are 
classically computed among voxels binary selected in the 
segmentation step. We proposed the use of fuzzy-threshold, 
providing tumor membership probability map, and present a 
generalization of the computation of FDG PET parameters by 
weighting each PET voxel by its tumor membership 
probability. The goal of the study was to evaluate the 
relevance of fuzzy-threshold based weighted parameters in 
prediction of tumor recurrence, in comparison with a 
“standard” fixed or hard threshold based parameters. 
 
Material and Methods: This study included 53 patients 
treated for locally advanced cervical cancer by external 
beam radiation therapy with concurrent chemotherapy, 
followed by brachytherapy and ± surgery. All patient 
underwent 18F-FDG PET/CT exam before the treatment. 
Different tumor membership probability maps were extracted 
from 18F-FDG PET images using fuzzy-thresholding defined by 
a threshold Th and a level of fuzziness ΔTh (both expressed in 
% of the maximum uptake value) using a Zadeh's standard 
function. Fuzzy-thresholding were tested with Th=41%, 50% 
and 70% and ΔTh from 0% to 40% (ΔTh=0% corresponding to 
hard-thresholding). Using the fuzzy-thresholding, we 
computed weighted analogs of four standard 18F-FDG PET 
parameters; the maximum uptake averaged by its 26 
neighbors (SUVpeak), the average SUV inside the tumor 
region (SUVmean), the metabolic tumor volume (MTV) and 
the total lesion glycolysis (TLG). The recurrence was defined 
based on clinical examination, MRI and PET imaging. Median 
follow-up was 49 months [range: 7-83]. A total of 16 patients 
developed disease recurrence. The predictive capability of 
the PET parameters to predict 3 year overall recurrence were 
evaluated using the area under the receiver operating 
characteristic curve (AUC) and the p-value of the logistic 
regression model. 
 
Results: The figure shows the predictive values (AUC and p 
values) of the weighted parameters depending on the 
threshold Th and the fuzzy-level Δth used. SUVpeak and 
SUVmean were not predictive for any of the segmentations 
tested. TLG and MTV extracted through hard-thresholding 
(ΔTh=0%) were highly predictive with Th=41% (AUC=0.74, 
p=0.012) and Th=50% (AUC=0.77, p=0.006) but not with 
Th=70%. Weighted parameters were discriminative (p<0.05) 
at Th=41% with Δth = [0% - 22%], at Th=50% with Δth = [0% - 
32%] and at Th=70% with Δth = [0% - 32%] indicating a lower 
sensitivity to the choice of threshold. 
 
 
Conclusion: PET weighted parameters including voxels tumor 
membership probability can be used to predict tumor 
